Quanterix (QTRX) Competitors

In the previous week, Ginkgo Bioworks had 3 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for Ginkgo Bioworks and 7 mentions for Quanterix. Ginkgo Bioworks' average media sentiment score of 0.30 beat Quanterix's score of 0.06 indicating that Ginkgo Bioworks is being referred to more favorably in the media.

Ginkgo Bioworks has a beta of 1.76, meaning that its stock price is 76% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

Ginkgo Bioworks presently has a consensus target price of $6.33, suggesting a potential downside of 19.62%. Quanterix has a consensus target price of $3.00, suggesting a potential downside of 2.28%. Given Quanterix's stronger consensus rating and higher probable upside, analysts plainly believe Quanterix is more favorable than Ginkgo Bioworks.

Quanterix has lower revenue, but higher earnings than Ginkgo Bioworks. Ginkgo Bioworks is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Quanterix has a net margin of -80.25% compared to Ginkgo Bioworks' net margin of -259.96%. Quanterix's return on equity of -26.09% beat Ginkgo Bioworks' return on equity.

78.6% of Ginkgo Bioworks shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 12.7% of Ginkgo Bioworks shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

86.5% of Quanterix shares are owned by institutional investors. 3.7% of Pacific Biosciences of California shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Quanterix has a net margin of -80.25% compared to Pacific Biosciences of California's net margin of -82.49%. Quanterix's return on equity of -26.09% beat Pacific Biosciences of California's return on equity.

Pacific Biosciences of California has a beta of 2.31, suggesting that its share price is 131% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Pacific Biosciences of California currently has a consensus target price of $1.71, indicating a potential upside of 25.00%. Quanterix has a consensus target price of $3.00, indicating a potential downside of 2.28%. Given Pacific Biosciences of California's stronger consensus rating and higher probable upside, equities analysts clearly believe Pacific Biosciences of California is more favorable than Quanterix.

Quanterix has lower revenue, but higher earnings than Pacific Biosciences of California. Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

In the previous week, Quanterix had 4 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 7 mentions for Quanterix and 3 mentions for Pacific Biosciences of California. Pacific Biosciences of California's average media sentiment score of 0.67 beat Quanterix's score of 0.06 indicating that Pacific Biosciences of California is being referred to more favorably in the media.

Simulations Plus currently has a consensus price target of $17.25, indicating a potential downside of 6.45%. Quanterix has a consensus price target of $3.00, indicating a potential downside of 2.28%. Given Quanterix's higher probable upside, analysts plainly believe Quanterix is more favorable than Simulations Plus.

In the previous week, Quanterix had 4 more articles in the media than Simulations Plus. MarketBeat recorded 7 mentions for Quanterix and 3 mentions for Simulations Plus. Simulations Plus' average media sentiment score of 0.53 beat Quanterix's score of 0.06 indicating that Simulations Plus is being referred to more favorably in the media.

78.1% of Simulations Plus shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 19.1% of Simulations Plus shares are held by insiders. Comparatively, 1.5% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Simulations Plus has higher earnings, but lower revenue than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

Simulations Plus has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Simulations Plus has a net margin of 9.88% compared to Quanterix's net margin of -80.25%. Simulations Plus' return on equity of 13.50% beat Quanterix's return on equity.

In the previous week, Alpha Teknova had 1 more articles in the media than Quanterix. MarketBeat recorded 8 mentions for Alpha Teknova and 7 mentions for Quanterix. Alpha Teknova's average media sentiment score of 0.63 beat Quanterix's score of 0.06 indicating that Alpha Teknova is being referred to more favorably in the news media.

86.5% of Quanterix shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 1.5% of Quanterix shares are held by company insiders. Comparatively, 13.2% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Quanterix has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Quanterix currently has a consensus target price of $3.00, indicating a potential downside of 2.28%. Alpha Teknova has a consensus target price of $8.00, indicating a potential upside of 2.70%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Quanterix.

Alpha Teknova has a net margin of -38.37% compared to Quanterix's net margin of -80.25%. Alpha Teknova's return on equity of -24.94% beat Quanterix's return on equity.

Alpha Teknova has lower revenue, but higher earnings than Quanterix. Alpha Teknova is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.